Home » Topics » Regulatory » EMA

EMA
RSS

Tracon Pharmaceuticals's TRC-105 obtains E.U. orphan drug designation

May 5, 2016

EMA grants accelerated assessment to cerliponase alfa MAA

May 4, 2016

EMA committee recommends approval of Ongentys

May 3, 2016

EMA's CHMP recommends approval of HyQvia in pediatric patients

May 3, 2016

CHMP recommends E.U. approval of Gazyvaro for treatment of previously treated follicular lymphoma

May 3, 2016

EMA committee backs marketing authorization for Enzepi

May 2, 2016

CHMP backs approval of Imbruvica in CLL

May 2, 2016

Avibactam/ceftazidime gets positive opinion from CHMP

May 2, 2016

Daclizumab recommended for approval in E.U.

May 2, 2016

Gilead's MAA for Odefsey single tablet regimen receives positive opinion for the treatment of HIV

May 2, 2016

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...